logo
logo

Gfbiochemicals Raises €15M Series A To Advance Its Mission To End Chemical Pollution

May 05, 2022•about 3 years ago

Amount Raised

€15 Million

Round Type

series a

Paris

Description

PARIS, FRANCE / May 5, 2022 / GFBiochemicals, a leading sustainable chemical company, today announced a €15 million Series A funding round led by Sofinnova Partners, with participation from Sparta Capital. At a time when the chemical crisis has already passed the safe limit for human health and the environment, the round will accelerate GFBiochemicals' mission to end chemical pollution. The company aims to help fast moving consumer goods (FMCG) and industrial companies transition away from using toxic, environmentally harmful petrochemicals in everyday products.

Company Information

Company

Gf Biochemicals

Location

Paris, Texas, United States

About

Headquartered in Paris, GFBiochemicals is a leading sustainable chemical company with a mission to end chemical pollution. We provide the companies who make our everyday products with safe, sustainable solvents and ingredients derived from the biobased levulinic molecule. This has three benefits: it ensures that everyday products are biodegradable, non-harmful and carbon friendly. GFBiochemicals has offices and R&D facilities in the Netherlands and the United States, operations in India, and over 200 active patents across 40 patent families. Through our Joint Venture, NXTLEVVEL, we leverage our proprietary technology to enable commercial-scale manufacturing of our product. For more information, please visit: http://www.gfbiochemicals.com/company/.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech